Get started
Author

A Rodríguez Rodríguez

Observed name: Alejandro Rodríguez Rodríguez
ORCID: 0009-0008-3606-5259
Observed ORCID: 0009-0008-3606-5259
OpenAlex ID: A5130105919
Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk
2026 · Alejandro Rodríguez Rodríguez, Sandra Caíña López, et al. · European Journal of Hospital Pharmacy
Modulation of cytochrome P450 and P-glycoprotein by Ashwagandha ( Withania somnifera ): implications for CDK4/6 inhibitor therapy
2026 · Alejandro Rodríguez Rodríguez, Sandra Caíña López, et al. · European Journal of Hospital Pharmacy
5PSQ-065 Endophthalmitis as an adverse reaction to intravitreal administration of aflibercept and ranibizumab
2026 · S Caíña López, A Bartolomé Figueroa, et al. · European Journal of Hospital Pharmacy
Works count: 3
Citation count:
H-index:
I10-index:
Year
Topic
Type